Tailoring immunosuppressive therapy based on donor and recipient risk factorsFIRST, M. R.Transplantation proceedings. 2001, Vol 33, Num 3, pp 2207-2211, issn 0041-1345Conference Paper

Long-term complications after transplantationFIRST, M. R.American journal of kidney diseases. 1993, Vol 22, Num 3, pp 477-486, issn 0272-6386Article

An update on new immunosuppressive drugs undergoing preclinical and clinical trials: Potential applications in organ transplantationFIRST, M. R.American journal of kidney diseases. 1997, Vol 29, Num 2, pp 303-317, issn 0272-6386Article

Recurrence of cyclosporine nephropathy in a heart transplant recipientCAVALLO, T; FIRST, M. R.American journal of kidney diseases. 1996, Vol 28, Num 3, pp 466-468, issn 0272-6386Article

Merkel's cell carcinoma in organ recipients: Report of 41 casesPENN, I; FIRST, M. R.Transplantation. 1999, Vol 68, Num 11, pp 1717-1721, issn 0041-1337Article

Development of Sang-35 : a cyclosporine formulation bioequivalent to NeoralFIRST, M. R; ALLOWAY, R; SCHROEDER, T. J et al.Clinical transplantation. 1998, Vol 12, Num 6, pp 518-524, issn 0902-0063Article

Detection of Epstein-Barr virus message in renal allograftsVIERO, R. M; FIRST, M. R; CAVALLO, T et al.Transplantation. 1996, Vol 61, Num 2, pp 321-323, issn 0041-1337Article

Monoclonal antibodies in organ transplantationSCHROEDER, T. J; FIRST, M. R.American journal of kidney diseases. 1994, Vol 23, Num 1, pp 138-147, issn 0272-6386Article

Effect of race on renal transplant outcomeHARIHARAN, S; SCHROEDER, T. J; FIRST, M. R et al.Clinical transplantation. 1993, Vol 7, Num 3, pp 235-239, issn 0902-0063Conference Paper

Disseminated histoplasmosis in renal allograft recipientsRAM PEDDI, V; SUNDARAM HARIHARAN; FIRST, M. R et al.Clinical transplantation. 1996, Vol 10, Num 2, pp 160-165, issn 0902-0063Article

Growth and grazing rates of bacteria groups with different apparent DNA content in the Gulf of MexicoJOCHEM, F. J; LAVRENTYEV, P. J; FIRST, M. R et al.Marine biology (Berlin). 2004, Vol 145, Num 6, pp 1213-1225, issn 0025-3162, 13 p.Article

Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccineLINNEMANN, C. C. JR; FIRST, M. R; SCHIFFMAN, G et al.Archives of internal medicine (1960). 1986, Vol 146, Num 8, pp 1554-1556, issn 0003-9926Article

Increased resources are required in patients with low cyclosporine bioavailabilitySCHROEDER, T. J; SHAH, M; HARIHARAN, S et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2151-2155, issn 0041-1345Conference Paper

Erythromycin-induced hearing loss in immunosuppressed transplant patientsSTERNBERG, R. I; BAUGHMAN, R. P; FIRST, M. R et al.Clinical transplantation. 1993, Vol 7, Num 3, pp 269-272, issn 0902-0063Article

Diabetic nephropathy after renal transplantation : Clinical and pathologic featuresHARIHARAN, S; SMITH, R. D; VIERO, R et al.Transplantation. 1996, Vol 62, Num 5, pp 632-635, issn 0041-1337Article

Evaluation of flowcytometric crossmatching in renal allograft recipientsSRIDHAR, N. R; RINO MUNDA; KAMALA BALAKRISHNAN et al.Nephron. 1992, Vol 62, Num 3, pp 262-266, issn 0028-2766Article

Effect of cyclosporine on fractional excretion of sodium in renal transplant patientsSHAH, B. V; HONG, C. D; FIRST, M. R et al.Clinical transplantation. 1990, Vol 4, Num 2, pp 102-107, issn 0902-0063, 6 p.Article

Primary care of patients with renal transplantsRAM PEDDI, V; FIRST, M. R.The Medical clinics of North America. 1997, Vol 81, Num 3, pp 767-784, issn 0025-7125Article

Transplant glomerulopathy: evolution of morphologically distinct changesMARYNIAK, R. K; FIRST, M. R; WEISS, M. A et al.Kidney international. 1985, Vol 27, Num 5, pp 799-806, issn 0085-2538Article

Conversion of stable kidney transplant recipients from a twice daily prograf-based regimen to a once daily modified release tacrolimus-based regimenALLOWAY, R; STEINBERG, S; WISEMANDLE, K et al.Transplantation proceedings. 2005, Vol 37, Num 2, pp 867-870, issn 0041-1345, 4 p.Conference Paper

The evaluation of the safety and tolerability of two formulations of cyclosporine : Neoral and sandimmune a meta-analysisSHAH, M. B; MARTIN, J. E; SCHROEDER, T. J et al.Transplantation. 1999, Vol 67, Num 11, pp 1411-1417, issn 0041-1337Article

Mycophenolate mofetil-lnduced colonic ulceration in renal transplant recipientsGOLCONDA, M. S; VALENTE, J. F; BEJARANO, P et al.Transplantation proceedings. 1999, Vol 31, Num 1-2, pp 272-273, issn 0041-1345Conference Paper

Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from sandimmuneFIRST, M. R; WEISKITTEL, P; BURTON, M. L et al.Transplantation proceedings. 1999, Vol 31, Num 1-2, pp 324-325, issn 0041-1345Conference Paper

Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantationRAM PEDDI, V; KAMATH, S; MUNDA, R et al.Clinical transplantation. 1998, Vol 12, Num 5, pp 401-405, issn 0902-0063Article

Conversion of stable renal transplant recipients from sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence methodFIRST, M. R; WEISKITTEL, P; BURTON, M et al.Transplantation proceedings. 1998, Vol 30, Num 5, pp 1701-1705, issn 0041-1345Conference Paper